Human Feedback Types
strongExpert Verification
Directly usable for protocol triage.
"Ovarian tumour management has increasingly relied on multidisciplinary tumour board (MDT) deliberation to address treatment complexity and disease heterogeneity."
HFEPX · Eval paper review
Yangyang Zhang, Zilong Wang, Jianbo Xu, Yongqi Chen +23 more
Published
Feb 14, 2026
Citations
0
Trust level
Moderate
Usefulness score
40/100 (Low)
Extraction confidence
50% (Moderate)
Derived from extracted protocol signals and abstract evidence.
Rater population
Domain Experts
Signals refreshed
Feb 14, 2026
This paper is adjacent to HFEPX scope and is best used for background context, not as a primary protocol reference.
Use this for comparison and orientation, not as your only source.
Use this page for context, then validate protocol choices against stronger HFEPX references before implementation decisions.
Best use
Background context only
Use if you need
A secondary eval reference to pair with stronger protocol papers.
What to verify
Read the full paper before copying any benchmark, metric, or protocol choices.
Main weakness
The abstract does not clearly name benchmarks or metrics.
Treat as adjacent context, not a core eval-method reference.
If you are doing eval pipeline work, start here
Ovarian tumour management has increasingly relied on multidisciplinary tumour board (MDT) deliberation to address treatment complexity and disease heterogeneity. However, most patients worldwide lack access to timely expert consensus, particularly in resource-constrained centres where MDT resources are scarce or unavailable. Here we present OMGs (Ovarian tumour Multidisciplinary intelligent aGent System), a multi-agent AI framework where domain-specific agents deliberate collaboratively to integrate multidisciplinary evidence and generate MDT-style recommendations with transparent rationales. To systematically evaluate MDT recommendation quality, we developed SPEAR (Safety, Personalization, Evidence, Actionability, Robustness) and validated OMGs across diverse clinical scenarios spanning the care continuum. In multicentre re-evaluation, OMGs achieved performance comparable to expert MDT consensus ($4.45 \pm 0.30$ versus $4.53 \pm 0.23$), with higher Evidence scores (4.57 versus 3.92). In prospective multicentre evaluation (59 patients), OMGs demonstrated high concordance with routine MDT decisions. Critically, in paired human-AI studies, OMGs most substantially enhanced clinicians' recommendations in Evidence and Robustness, the dimensions most compromised when multidisciplinary expertise is unavailable. These findings suggest that multi-agent deliberative systems can achieve performance comparable to expert MDT consensus, with potential to expand access to specialized oncology expertise in resource-limited settings.
These are the protocol signals we could actually recover from the available paper metadata. Use them to decide whether this paper is worth deeper reading.
Expert Verification
Directly usable for protocol triage.
"Ovarian tumour management has increasingly relied on multidisciplinary tumour board (MDT) deliberation to address treatment complexity and disease heterogeneity."
None explicit
Validate eval design from full paper text.
"Ovarian tumour management has increasingly relied on multidisciplinary tumour board (MDT) deliberation to address treatment complexity and disease heterogeneity."
Not reported
No explicit QC controls found.
"Ovarian tumour management has increasingly relied on multidisciplinary tumour board (MDT) deliberation to address treatment complexity and disease heterogeneity."
Not extracted
No benchmark anchors detected.
"Ovarian tumour management has increasingly relied on multidisciplinary tumour board (MDT) deliberation to address treatment complexity and disease heterogeneity."
Not extracted
No metric anchors detected.
"Ovarian tumour management has increasingly relied on multidisciplinary tumour board (MDT) deliberation to address treatment complexity and disease heterogeneity."
Domain Experts
Helpful for staffing comparability.
"However, most patients worldwide lack access to timely expert consensus, particularly in resource-constrained centres where MDT resources are scarce or unavailable."
No benchmark or dataset names were extracted from the available abstract.
No metric terms were extracted from the available abstract.
Ovarian tumour management has increasingly relied on multidisciplinary tumour board (MDT) deliberation to address treatment complexity and disease heterogeneity.
Based on abstract + metadata only. Check the source paper before making high-confidence protocol decisions.
Human feedback protocol is explicit
Detected: Expert Verification
Evaluation mode is explicit
No clear evaluation mode extracted.
Quality control reporting appears
No calibration/adjudication/IAA control explicitly detected.
Benchmark or dataset anchors are present
No benchmark/dataset anchor extracted from abstract.
Metric reporting is present
No metric terms extracted.